Dr. Daniela Molena, MD

Dr. Molena practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Molena's NPI, 1336152487, was assigned on August 13, 2006. Dr. Molena graduated from University of Padua College of Medicine in 1996. Dr. Molena holds New York license 256288.

Dr. Molena's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Molena's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dr. Molena is also affiliated with Riverview Medical Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Molena to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Molena practices, 2 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Molena's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Molena is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Molena's licenses on file in 7 states: New York, California, Florida, Oregon, New Jersey, Maryland and Pennsylvania.

Dmand AI lists esophagus, stomach, or upper small intestine surgery and lung resection among the conditions Dr. Molena treats.

CMS data shows 332 Medicare services from Dr. Molena across 10 procedure codes in 2024, for 203 Medicare patients. Medicare paid $97,793 for them.

CMS counts 203 Medicare patients who saw Dr. Molena in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Molena's median patient age at 72, with 43% women.

In 2024, Dr. Molena wrote 20 Medicare Part D claims for 13 patients. 95% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Molena for performance year 2024, reported as part of a group. Dr. Molena accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Molena as offering telehealth. CMS counts 86 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Molena, more than 73% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 263 papers to Dr. Molena, published from 2001 to 2025. 2021 was the busiest year, with 31. The most frequent topics are Esophageal Neoplasms, Esophagectomy and Lung Neoplasms. Dr. Molena has published most often in J Thorac Cardiovasc Surg. Dr. Molena's most frequent co-authors are David R. Jones, Manjit S. Bains, MD and James M. Isbell, MD.

Dmand AI links Dr. Molena to 4 clinical trials. 3 are still active or recruiting. Conditions studied include Esophageal Neoplasms, Esophageal Diseases and Anxiety Disorders. Memorial Sloan Kettering Cancer Center sponsors the most, 4.

CMS Open Payments shows 211 general payments to Dr. Molena from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. AstraZeneca Pharmaceuticals LP paid the most, $117,864.

Dmand AI lists 7 awards for Dr. Molena, most recently ACS Fellow in 2014.

Dr. Molena graduated from University of Padua College of Medicine in 1996. Dr. Molena is a member of ACS and STS.

Dr. Molena is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.